Related by context. All words. (Click for frequent words.) 63 selectively binds 62 generation purine nucleoside 61 5HT 61 receptor blocker 61 Angiotensin 61 Nucleoside 61 5 hydroxytryptamine 61 vapreotide acetate 61 Novel Oral 60 cortisol synthesis 60 ergot derivatives 60 luteinizing hormone releasing 60 downregulates 60 Janus Kinase 60 hormone LHRH 60 Angiotensin Converting Enzyme 60 Interferon gamma 60 Mg Uk 59 soluble tumor necrosis 59 terfenadine 59 selective antagonist 59 Reductase 59 peptide CGRP 59 covalently bound 59 cyclin dependent kinase inhibitor 59 Zorbtive TM 59 cell adhesion molecule 59 systemic juvenile idiopathic 59 Janus kinase 59 cytidine 59 pharmacologically active isomer 59 Lenalidomide 59 Pharmacokinetics PK 59 imipramine Tofranil 59 Recombinant Human 59 gene polymorphism 59 humanized monoclonal 58 isoenzyme 58 Tumor necrosis factor 58 mediated apoptosis 58 calcitonin gene related 58 somatostatin 58 PEG IFN 58 Orally administered 58 muscarinic receptor 58 selective modulator 58 vesicular monoamine transporter 58 Meets Primary Endpoint 58 mineralocorticoid 58 Fludarabine 58 mitogen activated protein 58 thymidine 58 deoxy 58 Vidaza ® 58 Vidaza R 58 Mg Usa 58 metastatic malignant 58 cetuximab Erbitux R 58 Fibroblast Growth Factor 58 Upregulation 58 cyclophosphamide methotrexate 57 protein tyrosine phosphatase 1B 57 refractory chronic lymphocytic 57 5 HT2A serotonin 57 ,#,# [002] 57 Azacitidine 57 thalidomide Thalomid 57 colony stimulating factor 57 monocyte chemotactic protein 57 mineralocorticoid receptor 57 include ELND# AZD 57 Adjuvant Treatment 57 enkephalin 57 hyaluronidase enzyme 57 ® lenalidomide 57 NS5B polymerase 57 Lymphocytic 57 Interferon Alpha 57 Medoxomil 57 norepinephrine reuptake inhibitor SNRI 57 #mg/#mg 57 2 methoxyestradiol 57 Intravitreal 57 Factor Receptor 57 liposome encapsulated 57 sodium glucose cotransporter 57 CD# CD# 57 irreversible inhibitor 57 adriamycin 57 essential thrombocythemia ET 57 complement inhibitor eculizumab 57 Attenuates 57 selective agonist 57 Kuvan sapropterin dihydrochloride 57 developing Bicifadine serotonin 57 dacarbazine DTIC 57 cyclin dependent kinase 57 potent antiproliferative 56 vinorelbine tartrate 56 mediated phosphorylation 56 cholesteryl ester transfer 56 D aspartate 56 bexarotene 56 Receptor Agonist 56 Parathyroid Hormone 56 Files IND 56 Î ² 56 potently inhibits 56 Peginterferon Alfa 2a 56 Myelodysplastic Syndrome MDS 56 COPEGUS R 56 upregulates 56 aurora kinase 56 PDGFR alpha 56 CDK inhibitor 56 leukemia AML 56 mediated inhibition 56 receptor partial agonist 56 Boniva ibandronate 56 receptor CXCR4 56 LHRH receptor positive 56 cis retinoic acid 56 glycogen synthase kinase 56 gemcitabine Gemzar 56 Angiotensin II 56 5alpha 56 plasminogen activator inhibitor 56 PEGylated Fab fragment 56 Saizen ® 56 tissue transglutaminase 56 tumor xenograft models 56 R Saizen R 56 exendin 4 56 gonadotropin releasing hormone GnRH 56 cyclooxygenase COX 56 Epidermal Growth Factor 56 Glycosylation 56 Multiple Myeloma MM 56 phenothiazines 56 mTOR mammalian target 56 thrombin receptor 56 CYP#A# CYP#D# 56 SSc 56 Exendin 4 56 chronic thromboembolic pulmonary 56 induces apoptosis 56 mitoxantrone plus 56 glutamyl 56 factor PDGF 56 hydroxylase 56 calcium calmodulin dependent 56 2A receptor agonist 56 regulated kinase 56 Completes Patient Enrollment 56 Interferon alpha 2b 56 serotonin norepinephrine 56 antiapoptotic 56 ceftazidime 56 Secretase 56 bevacizumab Avastin R 56 P2X 56 Posaconazole 56 orally administered inhibitor 55 Ranibizumab 55 FOLFOX6 55 selectively inhibits 55 alpha interferons 55 generation antisense inhibitor 55 methylenetetrahydrofolate reductase 55 liposomal formulation 55 dihydrochloride 55 potential vanilloid 55 IGF1R 55 Hsp# Inhibitor 55 Neovascularization 55 serine threonine kinase 55 Patients Treated With 55 nortriptyline Pamelor 55 Catenin 55 Gly 55 diarrhea predominant irritable 55 selective A2A adenosine receptor 55 neurokinin 55 mGluRs 55 nadolol 55 Orally Active 55 Myeloid 55 phospholipase 55 erlotinib Tarceva ® 55 carboxypeptidase 55 #ß 55 papillary renal cell carcinoma 55 N methyl 55 aMCI precursor 55 promoter polymorphism 55 adrenoceptor 55 PRN FDA Approves 55 GSTP1 55 PEGylated anti 55 Granulocyte Colony Stimulating Factor 55 interleukin IL -# 55 Combination REOLYSIN R 55 Bicalutamide 55 V#F mutation 55 dasatinib Sprycel 55 novel VDA molecule 55 beta 1a 55 Tambocor 55 DNA intercalator 55 Gonal f R 55 TrkB 55 factor receptor EGFr 55 benign neoplasms 55 cyclooxygenase 55 induced phosphorylation 55 efavirenz EFV 55 receptor blockers 55 corticotropin 55 Ibritumomab Tiuxetan 55 Pegylated interferon 55 ELND# AZD 55 ABLYNX 55 pyridoxine 55 Fas ligand 55 N acetyl 55 Bosutinib 55 ara C 55 metabolizing enzyme 55 C#Y 55 prostaglandin E1 55 #mg #mg #mg [003] 55 Oral Fingolimod 55 orally inhaled 55 serine threonine 55 Vascular endothelial growth 55 factor EGF 55 molecule epidermal 55 Dehydrogenase 55 HER1 55 xenograft model 55 Hos2 55 cromolyn sodium 55 cisplatin gemcitabine 55 Preclinical studies suggest 55 Fludara ® 55 tazobactam 55 matrix metalloproteases 55 Cyclooxygenase 55 FEMALES SHOULD BE ADVISED 55 sulfonamide 55 MetroGel 55 iobenguane 55 constitutively activated 55 Mycophenolate Mofetil 55 Isavuconazole 54 BUPHENYL R sodium phenylbutyrate 54 chimeric monoclonal antibody 54 thymidine kinase 54 Prodrug 54 acyltransferase 54 pharyngitis tonsillitis 54 Adrenergic 54 gamma agonists 54 interleukin IL -6 54 Serostim R 54 topical gel formulation 54 Study Evaluating 54 muscarinic 54 receptor antagonism 54 Receives Orphan Drug Designation 54 peptidic compound 54 inhibit VEGF 54 Hydralazine 54 Peginterferon alfa 2a 54 inhibitor COX 54 Chemokine Receptor 54 TO AVOID PREGNANCY WHILE 54 Interferon beta 54 receptor modulator 54 selective adenosine 54 murine model 54 muscarinic receptors 54 Soft Tissue Sarcoma 54 M1 muscarinic 54 myelodysplastic myeloproliferative diseases 54 Leukopenia neutropenia 54 small molecule thrombopoietin 54 Aurora Kinase 54 idiopathic generalized epilepsy 54 radiosensitivity 54 cytopenias 54 Paraplatin ® 54 phorbol 54 alpha2 54 mitogen activated protein kinase 54 prostanoid 54 gastrointestinal stromal tumors GISTs 54 Apolipoprotein E 54 targetters 54 inflammatory PDE 54 Adenoscan R 54 Relapsed Refractory 54 idiopathic PAH 54 Bcl 54 methoxy 54 Overexpression 54 ErbB1 54 fumarate 54 MET VEGFR2 54 Synthase 54 glucocorticoid induced 54 receptor tyrosine kinase 54 induce orthostatic hypotension 54 folinic acid 54 Oral Formulation 54 intercellular adhesion molecule 54 Drug Candidate 54 Pooled Analysis 54 Anti VEGF 54 isoenzymes 54 Supplemental Figure 54 Fibroblast Growth Factor Receptor 54 treat benign prostatic 54 5 HT4 54 myelofibrosis polycythemia vera 54 syngeneic 54 methionine aminopeptidase 54 interferon alfa 2b 54 converting enzyme 54 TRAIL R1 54 plasmid encoding 54 cell acute lymphoblastic 54 1α 54 Sustiva efavirenz 54 Interferon beta 1a 54 Phosphodiesterase 54 alkylating agent 54 relapsed acute myelogenous 54 LPS induced 54 Shows Promise Against 54 Signaling Pathway 54 TNF Tumor Necrosis Factor 54 tyrosine hydroxylase 54 phosphatidylinositol 3 54 Angiotensin converting enzyme 54 glucosidase 54 Monocyte 54 Transdermal Patch 54 decarboxylase 54 potentially hepatotoxic 54 Neulasta R 54 lexidronam injection 54 guanosine 54 sapropterin dihydrochloride 54 partial agonist 54 Achieves Primary Endpoint 54 constitutively active 54 1MG TAB 54 diphosphate 54 ^ sup #m 54 microsomal 54 ® tiagabine hydrochloride 54 secondary hyperparathyroidism 54 chemokine SDF 1 54 intranasal formulation 54 IgG1 54 EP4 54 uroguanylin 54 HLA DR4 54 Tyrosine Kinase Inhibitor 54 transferase 54 phosphatidylinositol 54 CYT# potent vascular disrupting 54 highly selective inhibitor 54 Topoisomerase II 54 highly selective endothelin 54 PTHrP 54 Leukine ® 54 COL#A# 54 triiodothyronine T3 53 Thiazolidinediones 53 Xanafide 53 potently inhibit 53 bone morphogenetic protein 53 receptor inhibitor 53 Prospective Randomized 53 PDGF receptor 53 hypereosinophilic syndrome 53 antiproliferative activity 53 LRAT 53 congenital deficiency 53 polyglutamate 53 LNCaP 53 MMP2 53 chemokine receptor 53 Transgenic Mice 53 Factor VEGF 53 Pegylated Liposomal Doxorubicin 53 dornase alfa 53 arginine vasopressin AVP 53 receptor subtypes 53 thrombospondin 53 P2Y 53 gene locus 53 investigational oral inhibitor 53 granulocyte macrophage colony stimulating 53 Flt3 53 phosphoinositide 53 receptor alpha 53 Ph + acute lymphoblastic 53 secretagogue 53 Phase IIa Clinical Trial 53 Glucocorticoid 53 colorectal carcinoma 53 Sapacitabine 53 autosomal recessive disorder 53 dopamine D2 53 immune modulator 53 poly ADP ribose polymerase 53 Retinoic Acid 53 factor HGF 53 surgically resected 53 alkylating 53 Caveolin 1 53 Antitumor 53 bFGF 53 IL8 53 Sezary syndrome 53 Advanced Renal Cell 53 selectively inhibited 53 mycophenolic acid 53 Captopril 53 5 HT2A 53 Hormone Refractory Prostate Cancer 53 R bisoprolol Euthyrox 53 autocrine 53 Galectin 53 Androgen Receptor 53 erosive gastritis 53 reductase 53 D aspartate NMDA receptor 53 Clindamycin 53 atrial natriuretic peptide 53 immunostimulatory 53 benign prostatic hypertrophy BPH 53 ERalpha 53 fluticasone propionate FP 53 Ovitrelle R Serostim 53 Serum concentrations 53 annexin 53 Modulates 53 nicotinic receptor 53 phosphorylates 53 adenosine 5' triphosphate ATP 53 Tubulin 53 Platelet Derived Growth 53 ERK1 2 53 Sevelamer 53 γ secretase 53 COX2 53 metalloproteinase 53 lipoxygenase 53 Neurol 53 RFF Pen 53 Diovan Exforge Tekturna Zelnorm 53 Is Well Tolerated 53 #HT#A 53 arsenic trioxide injection 53 hepatic lipase 53 Albuferon TM 53 topoisomerase II inhibitor 53 db db mice 53 aspartate 53 upregulating 53 Cytochrome P# 53 Immunomodulatory 53 chronic eosinophilic leukemia 53 methyl CpG binding 53 Initiates Phase II 53 related apoptosis inducing 53 regulator CFTR gene 53 VEGFR2 inhibitor 53 Monopril 53 Serostim ® 53 integrin alpha 53 Lamotrigine 53 TNF IL 53 Inhibits 53 Selective Inhibitor 53 Brain Derived Neurotrophic 53 gag pol 53 human platelet derived 53 Dysregulation 53 erythematosus 53 Tiotropium 53 osteogenic 53 Glucocorticoids 53 Protein Kinase C 53 DNA methyltransferase 53 caveolin 53 Sanofi Aventis Taxotere 53 potent inducer 53 ACC2 53 Prognostic significance 53 Granted Orphan Drug 53 Transmembrane 53 targeted antifolate 53 Refractory Hodgkin Lymphoma 53 mu opioid receptor antagonist 53 Cutaneous T 53 ^ Tc 53 Inappropriate activation 53 5 HT1A receptor 53 Triamcinolone 52 inhibit vascular endothelial 52 l lysine 52 MTHFR 52 glucose dependent insulinotropic 52 Lanthanum Carbonate 52 Prolongs Survival 52 TRAIL receptors 52 Mometasone 52 refractory cutaneous T 52 MEK1 52 Pivotal Phase III 52 Solaraze 52 apoptosis inducing 52 Antitumor Activity 52 Phosphorylation 52 J Am Acad 52 Nilotinib 52 Naive Patients 52 Actinic Keratosis 52 muscarinic antagonist 52 MTP inhibitor 52 Alfacell proprietary ribonuclease 52 extracellular signal 52 Sanofi Pasteur Fluzone 52 Non Alcoholic Steatohepatitis 52 targeted radiotherapeutic 52 gastric carcinoma 52 anti angiogenic agent 52 Immunoassay Systems 52 induced macular edema 52 Tumour Necrosis Factor 52 triciribine phosphate monohydrate 52 IAP inhibitor 52 epithelial sodium 52 Antigen Specific 52 Drug Eluting Stent System 52 IGF binding 52 prescription laxative 52 HER2 ErbB2 52 tetracycline antibiotic 52 pathophysiological effects 52 Haemophilus b Conjugate 52 bioavailable testosterone 52 Neovascular Age Related Macular 52 Tezampanel 52 agonists antagonists 52 monocytic 52 oral nucleoside analogue 52 Previously Treated 52 Biolimus A9 52 Conjugate 52 Alanine 52 neutropenia thrombocytopenia 52 monocytes macrophages 52 Vitrasert R 52 prolyl 52 TNF α 52 ERK pathway 52 ADAMTS# 52 PKC inhibitor 52 #β estradiol 52 acyl CoA 52 J Am Soc 52 PDGFRA 52 activin receptor type 52 substrates inhibitors 52 hnRNP 52 factor G CSF 52 p# mitogen activated 52 Endothelin 52 NR2B selective 52 Peginterferon 52 Initiates Enrollment 52 indinavir Crixivan 52 FDA APPROVES 52 hypoxia selective 52 methyl D aspartate 52 deoxyglucose 52 somatropin Kuvan R 52 IN PATIENTS WITH 52 CYP3A 52 cyclic nucleotide 52 mitogenic 52 bone morphogenic protein 52 iduronate 2 52 HCV RNA polymerase 52 intracellular accumulation 52 thyroid peroxidase 52 mequinol 52 striatal dopamine 52 hepatocellular carcinomas 52 AN# topical anti 52 Squamous 52 5alpha reductase 52 acid GABA 52 interferon beta 1a infertility 52 familial amyloidotic polyneuropathy FAP 52 TIMP 1 52 Tie2 52 Topoisomerase 52 MOG #-# 52 Chemotherapy Induced 52 CD3 + 52 Polymerase 52 Chronic lymphocytic leukemia 52 ANCA associated 52 Trial Evaluating 52 methyltransferase 52 factor VIIa 52 AT1R 52 Letairis ambrisentan 52 R roscovitine CDK cyclin 52 beta2 52 Submits NDA 52 Tumor Necrosis Factor 52 thyroxine T4 52 cyclooxygenase 2 52 Topical Solution 52 inverse agonist 52 Piperacillin 52 Macrophage 52 downstream effector 52 pro angiogenic 52 J Am Coll 52 FOLFOX6 chemotherapy regimen 52 receptor subtype 52 Synuclein 52 Tyrosine 52 neutropenia dehydration dyspnea 52 vaginal candidiasis 52 immunofluorescence staining 52 tricalcium phosphate 52 platelet derived growth 52 serine protease 52 dihydrofolate reductase 52 Cytochrome 52 Complicated Skin 52 N acetylgalactosamine 52 null mice 52 c myc gene 52 Cyclophosphamide 52 Improves Outcomes 52 erythematosus SLE 52 cytokines IL 52 cytokine signaling 52 Brain derived neurotrophic 52 5 HT1A 52 HepDirect prodrug 52 cytotoxic T lymphocyte 52 essential thrombocythemia 52 P#Y# [001] 52 tiuxetan 52 lymphoid tumors 52 A2a 52 glucose transporter 52 induced apoptosis 52 Friedreich Ataxia FRDA 52 TRAF1 52 abacavir sulfate lamivudine 52 itraconazole Sporanox 51 pDC 51 TIMP 51 glutamatergic 51 class anticancer quinolone 51 hepatoma 51 herpes simplex viruses 51 uM 51 triamcinolone acetonide 51 potent inhibitor 51 adipogenic 51 NMDAR 51 Seasonal Allergic Rhinitis 51 retinol binding protein 51 Chronic lymphocytic leukemia CLL 51 receptor monoclonal antibody 51 Peginterferon alfa 2b 51 hemodynamically significant 51 Histone Deacetylase 51 5 FU leucovorin 51 Pegloticase 51 RRM1 51 transcriptional repressor 51 inhibits angiogenesis 51 constitutively expressed 51 noradrenergic 51 potent cytotoxic 51 Lanoxin 51 Leydig cell 51 Rho kinase 51 opioid receptor antagonist 51 PNP inhibitor 51 Plus STAARVISC TM 51 Gonal f ® 51 deletion 5q 51 acetylcholine receptor 51 steroidogenic 51 microtubule associated 51 Methionine 51 Initiates Clinical Trials 51 VEGF receptor 51 Vascular Endothelial Growth 51 IMiDs ® 51 vinca alkaloid 51 Amgen Neulasta R 51 MAP kinase 51 LNCaP cells 51 Am J Clin 51 Ketorolac 51 Allogeneic 51 promoter methylation 51 immune thrombocytopenic purpura 51 aplastic anemia AA 51 prostaglandin E 51 Int J Obes Relat 51 reversible inhibitor 51 Type IIa 51 C#BL/#J 51 paraneoplastic 51 AAG geldanamycin analog 51 actinin 51 angiopoietin 51 TNF receptors 51 TNFalpha 51 TTR gene 51 Parnate 51 Chronic HCV 51 ESR1 51 G.# G.# 51 Plasmid DNA 51 ectopic expression 51 alveolar epithelial cells 51 delta gamma agonist 51 mg q#h 51 potent inhibition 51 neurite outgrowth 51 covalently linked 51 procainamide 51 p# MAPK 51 hPTH #-# 51 colorectal adenoma 51 Phase 2a Trial 51 regulated kinase ERK 51 intraperitoneal injection 51 FUSILEV enhances 51 Atomoxetine 51 glucan 51 TGF beta1 51 endogenous interferon alpha 51 anthracycline taxane 51 induced mucositis 51 thromboxane A2 51 alpha subunit 51 CHEAP ONLINE PHARMACY LOW 51 PDGF B 51 transient receptor 51 Benzyl 51 Saizen R 51 downregulation 51 methylnaltrexone bromide 51 atypical hemolytic uremic syndrome 51 Cilostazol 51 inhibitor IPI 51 V#E 51 5' monophosphate 51 Cytotoxic T 51 AG# [002] 51 IFN g 51 Angioedema 51 angiotensin converting enzyme inhibitor 51 DNA methyltransferase inhibitors 51 Adenosine 51 Shellgel TM injectable viscoelastic 51 temsirolimus Torisel 51 kinase pathway 51 polyamine 51 NMIBC 51 Epithelial 51 antisense oligonucleotide 51 sulfatase 51 REPRONEX R menotropins 51 interferon alpha IFN 51 potentiates 51 hormone refractory metastatic prostate 51 NAGS deficiency 51 pathway inhibitor 51 Polymorphisms 51 Phase 2a Clinical Trial 51 triphosphate 51 procollagen 51 PEGylated interferon 51 Tocopherol 51 Endocrinol 51 HER2 HER2 51 JAK2 enzyme 51 TrkA 51 Heterozygous 51 neutropenia fatigue 51 dipeptide 51 antisense inhibitor 51 ß1 51 Chronic Prostatitis 51 metabotropic glutamate receptors 51 inhibit oxidative stress 51 candesartan cilexetil 51 gene encodes 51 Eraxis 51 Antitumor activity 51 Adenoviral 51 Oncogenic 51 Clusterin 51 hypoxia inducible factor 51 NF kappaB activation 51 1beta 51 NFKB 51 histone deacetylase 51 hydrolase 51 melanocyte 51 Proteasome 51 cytotoxicity assays 51 metabolic disorders Saizen R 51 First Patient Dosed 51 Completes Enrollment 51 non porcine pancreatic 51 Prodarsan R 50 glycosylated 50 polycystin 50 HepG2 cells 50 TNF alpha IL 50 Therapeutic Competitors Report 50 pyrimidines 50 d4T stavudine Zerit 50 acute GvHD 50 prokinetic agent 50 Diabetic Neuropathy 50 nitric oxide synthase NOS 50 piperacillin 50 Leukemias 50 Node Positive 50 Seliciclib CYC# 50 CYP#A# [002] 50 urate oxidase 50 IL6 50 heparanase 50 phospholipase C 50 INDUSTRY ASSESSMENTS 50 NMDA N 50 Investigational Treatment 50 interstitial cystitis IC 50 TNF alpha selectively neutralizing 50 naturally occurring neuroprotective 50 matrix metalloproteinases MMPs 50 PI3K/Akt 50 anterior pituitary 50 Stomatitis 50 PDGFR 50 Monoamine Oxidase 50 Clemens Injections 50 treat chronic sinusitis 50 DG# compounds targeting 50 Muscarinic 50 L. rhamnosus 50 haematologic 50 benzoic acid hyoscyamine sulfate 50 dehydrogenase 50 receptor activator 50 peptidase 50 IMiDs R 50 heme oxygenase 1 50 Am J Obstet 50 inducible nitric oxide synthase 50 vaginalis 50 E#F# 50 steroidogenesis 50 Ribavirin causes 50 ERK signaling 50 plasmid DNA pDNA 50 drlg 50 glucocorticoid receptor 50 Sudhir Agrawal D.Phil 50 glycosyltransferase 50 pharmacological inhibition 50 oxacillin 50 Indomethacin 50 gamma aminobutyric acid 50 Valproic acid 50 corticotropin releasing hormone 50 BMP2 50 cMet 50 selective serotonin 2C receptor 50 receptor kinase 50 eslicarbazepine 50 interferon inducible 50 autosomal recessive 50 Tissue Factor 50 hypercholesterolaemia 50 phosphate dehydrogenase 50 Chronic Heart Failure 50 antithrombin III 50 ALN HPN 50 PGL# 50 pancreatic prostate 50 cell adhesion molecules 50 microsomal triglyceride transfer 50 xanthine oxidase 50 Hemorrhagic 50 Injectable Solution 50 hormone LHRH antagonist 50 replicon 50 Bazedoxifene 50 hereditary emphysema 50 lutropin alfa 50 TGF alpha 50 Cholesterol Lowering Drug 50 systemic lupus erythematosus rheumatoid 50 matrix metalloprotease 50 downregulated 50 erythroid 50 somatropin rDNA origin 50 cytokines chemokines 50 CYP#A# isoenzyme 50 beta globin 50 Nicotinamide 50 headache abdominal pain 50 Ad5FGF 4 50 acid phosphatase PAP 50 gamma amino butyric 50 PON1 50 alpha folate receptor 50 potent inducers 50 superoxide dismutase 50 osteoprotegerin 50 prostaglandin D2 50 LRP5 50 pharmaceutically acceptable 50 antiangiogenic agent 50 sexually transmitted pathogens 50 kidney urologic 50 CD8 + cytotoxic 50 #beta HSD1 50 Agonist 50 Intravitreal injections 50 Drug Shows Promise 50 leukemia inhibitory 50 Subtypes 50 DGAT1 50 glial derived neurotrophic 50 HIF 1a 50 phospholipase A2 50 beta. 50 hypertrichosis occurred 50 tubulin polymerization 50 transmembrane receptor 50 Previously Untreated 50 Dystrophin 50 Pivotal Trial 50 cystic fibrosis transmembrane conductance 50 1alpha 50 selective inverse agonist 50 Monoclonal 50 Single Dose 50 Aromatase 50 PROCTOCORT R 50 HDAC enzymes 50 hypothalamic pituitary adrenal axis 50 apolipoprotein 50 Glutamate 50 Rho GTPase 50 Bcl XL 50 Hyperlipidemia 50 Protein kinase C 50 Hepatocellular 50 lysyl oxidase 50 thymosin beta 4 50 triggers apoptosis 50 ErbB receptors 50 Inhalation Aerosol 50 eNOS 50 TRAIL R2 50 leukocyte adhesion 50 diarrhea vomiting rash 50 Crit Rev 50 receptor gamma 50 Acetate Rectal Suppositories 50 FGFR3 50 Initiates Clinical Trial